CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 208277-208374
Annnotations
CORD-19-Sentences
{"project":"CORD-19-Sentences","denotations":[{"id":"T66666","span":{"begin":0,"end":97},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"An oral challenge with celecoxib was well tolerated by the patient without any adverse responses."}
CORD-19_Custom_license_subset
{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T159","span":{"begin":0,"end":97},"obj":"Sentence"}],"text":"An oral challenge with celecoxib was well tolerated by the patient without any adverse responses."}
CORD-19-PD-MONDO
{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1933","span":{"begin":33,"end":36},"obj":"Disease"}],"attributes":[{"id":"A1933","pred":"mondo_id","subj":"T1933","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"}],"text":"An oral challenge with celecoxib was well tolerated by the patient without any adverse responses."}